Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

35.79
Delayed Data
As of Dec 08
 +1.19 / +3.44%
Today’s Change
29.85
Today|||52-Week Range
80.00
-54.43%
Year-to-Date

Today’s Trading

Previous close34.60
Today’s open34.75
Day’s range33.83 - 36.05
Volume1,105,493
Average volume (3 months)852,011
Market cap$1.3B
Dividend yield--
Data as of 12/08/2016

Growth & Valuation

Earnings growth (last year)-3.73%
Earnings growth (this year)-60.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+24.83%
P/E ratioNM
Price/Sales52.72
Price/Book21.01

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-0.90-2.28%
PCRXPacira Pharmaceutica...+0.85+2.63%
XNCRXencor Inc+0.15+0.56%
DEPODepomed Inc+0.14+0.70%
Data as of 12/08/2016

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$1.53
Annual revenue (last year)$51.5M
Annual profit (last year)-$105.7M
Net profit margin-205.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President &
Vice Chairman
Samir Chandrakant Patel
Corporate headquarters
New York, New York

Forecasts


Search for Jobs